ARTICLE | Finance
Mirae’s Western expansion
New Mirae/Celltrion VC fund will expand financial group into U.S., European biotech
March 17, 2017 9:34 PM UTC
Mirae Asset Financial Group is tapping the Western market experience of biosimilar company Celltrion Inc. (KOSDAQ:068270) to expand its VC investments outside of Asia.
The partners will jointly launch a healthcare fund this month. Each will contribute half of the fund’s W150 billion ($135 million), according to Mirae’s Hyun Tae Kim. ...
BCIQ Company Profiles